Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,003,629
-$237,450 QoQ
Shares Held
41,679
-5.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#1,326
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ausdal Financial Partners, Inc. holds $34,343,984 across 14 Drug Manufacturers - General names. PFE ranks #7 (2.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,231 | $9,872,508 | |
| 2 | ABBV |
AbbVie Inc.
|
39,096 | $9,838,116 | |
| 3 | JNJ |
Johnson & Johnson
|
18,662 | $4,739,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
23,933 | $3,075,390 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
15,985 | $2,019,544 | |
| 6 | AMGN |
Amgen Inc
|
2,893 | $1,047,612 | |
| 7 | PFE |
Pfizer Inc
This page
|
41,679 | $1,003,629 | |
| 8 | NVS |
Novartis AG
|
4,509 | $706,649 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,003,629 | 41,679 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,241,079 | 44,198 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,386,381 | 55,678 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,105,857 | 43,401 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $665,024 | 27,435 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $726,143 | 28,656 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $680,706 | 25,658 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $445,560 | 15,396 | Shares | Sole | 2024-10-04 | |
| 2024-06-30 | $418,776 | 14,967 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $388,083 | 13,985 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $375,594 | 13,046 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $654,344 | 19,727 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $756,965 | 20,637 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $849,170 | 20,813 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,107,245 | 21,609 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $946,660 | 21,633 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,088,971 | 20,770 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,108,499 | 21,412 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,515,518 | 25,665 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,151,936 | 26,783 | Shares | Sole | 2021-11-01 | |
| 2021-06-30 | $1,080,698 | 27,597 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $958,138 | 26,446 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $883,071 | 23,990 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $908,470 | 24,754 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $569,111 | 17,404 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $506,996 | 15,533 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||